These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34509431)

  • 1. Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy.
    Borrelli E; Grosso D; Barresi C; Lari G; Sacconi R; Senni C; Querques L; Bandello F; Querques G
    Am J Ophthalmol; 2022 Mar; 235():80-89. PubMed ID: 34509431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography biomarkers indicating visual enhancement in diabetic macular edema resolved through anti-VEGF therapy: OCT biomarkers in resolved DME.
    Viggiano P; Vujosevic S; Palumbo F; Grassi MO; Boscia G; Borrelli E; Reibaldi M; Sborgia L; Molfetta T; Evangelista F; Alessio G; Boscia F
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104042. PubMed ID: 38460657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study.
    Szeto SK; Hui VWK; Tang FY; Yang D; Sun ZH; Mohamed S; Chan CKM; Lai TYY; Cheung C
    Br J Ophthalmol; 2023 Apr; 107(4):525-533. PubMed ID: 34750100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
    Lee J; Moon BG; Cho AR; Yoon YH
    Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME).
    Guyon B; Elphege E; Flores M; Gauthier AS; Delbosc B; Saleh M
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6241-6247. PubMed ID: 29228252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTEGRITY OF OUTER RETINAL LAYERS AFTER RESOLUTION OF CENTRAL INVOLVED DIABETIC MACULAR EDEMA.
    Muftuoglu IK; Mendoza N; Gaber R; Alam M; You Q; Freeman WR
    Retina; 2017 Nov; 37(11):2015-2024. PubMed ID: 28092342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
    Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INFLUENCE OF VITRECTOMY SURGERY ON THE INTEGRITY OF OUTER RETINAL LAYERS IN DIABETIC MACULAR EDEMA.
    Uji A; Murakami T; Suzuma K; Yoshitake S; Arichika S; Ghashut R; Fujimoto M; Yoshimura N
    Retina; 2018 Jan; 38(1):163-172. PubMed ID: 28263219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
    Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
    Tang L; Luo D; Qiu Q; Xu GT; Zhang J
    Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema.
    Borrelli E; Barresi C; Feo A; Lari G; Grosso D; Querques L; Sacconi R; Bandello F; Querques G
    Sci Rep; 2023 Feb; 13(1):3224. PubMed ID: 36828954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 14. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
    Sun JK; Lin MM; Lammer J; Prager S; Sarangi R; Silva PS; Aiello LP
    JAMA Ophthalmol; 2014 Nov; 132(11):1309-16. PubMed ID: 25058813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional analysis of morphologic changes and visual outcomes in diabetic macular edema.
    Lee H; Kang KE; Chung H; Kim HC
    Jpn J Ophthalmol; 2019 May; 63(3):234-242. PubMed ID: 30783942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.
    Das R; Spence G; Hogg RE; Stevenson M; Chakravarthy U
    JAMA Ophthalmol; 2018 Feb; 136(2):202-208. PubMed ID: 29327033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Coherence Tomography Biomarkers in Bilateral Diabetic Macular Edema Patients with Asymmetric anti-VEGF Response.
    Koc F; Güven YZ; Egrilmez D; Aydın E
    Semin Ophthalmol; 2021 Aug; 36(5-6):444-451. PubMed ID: 33780313
    [No Abstract]   [Full Text] [Related]  

  • 18. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
    Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
    Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.